Search Orphan Drug Designations and Approvals
-
Generic Name: | 2-(2-phenylvinyl)-4-[-methylpiperazin-l-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt |
---|---|
Date Designated: | 01/29/2010 |
Orphan Designation: | Treatment of acute myeloid leukemia. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
EntreMed, Inc. 9640 Medical Center Drive Rockville, Maryland 20850 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-